TSE:SVA Sernova (SVA) Stock Price, News & Analysis C$0.12 +0.01 (+4.55%) As of 10:58 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesNews and Trends About Sernova Stock (TSE:SVA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sernova alerts:Sign Up Key Stats Today's RangeC$0.11▼C$0.1250-Day RangeC$0.10▼C$0.1452-Week RangeC$0.10▼C$0.20Volume5,000 shsAverage Volume115,260 shsMarket CapitalizationC$43.43 millionP/E RatioN/ADividend Yield7.86%Price TargetN/AConsensus RatingN/A Company Overview Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders. Read More Receive SVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SVA Stock News HeadlinesSERNOVA BIOTHERAPEUTICS INCJuly 28, 2026 | finanznachrichten.deSernova Biotherapeutics Inc.July 19, 2026 | barrons.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 2 at 1:00 AM | Stansberry Research (Ad)Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total PancreatectomyJune 17, 2026 | markets.businessinsider.comStocks in play: Sernova Biotherapeutics Inc.June 17, 2026 | ca.finance.yahoo.comSernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total ...June 17, 2026 | finanznachrichten.deOff-market insider buying at Sernova Biotherapeutics (SVA)April 18, 2026 | theglobeandmail.comSernova Biotherapeutics: Sernova Biotherapeutics Announces Warrant AmendmentsFebruary 20, 2026 | finanznachrichten.deSee More Headlines SVA Stock Analysis - Frequently Asked Questions How have SVA shares performed this year? Sernova's stock was trading at C$0.13 on January 1st, 2026. Since then, SVA shares have decreased by 11.5% and is now trading at C$0.12. How were Sernova's earnings last quarter? Sernova Corp. (TSE:SVA) announced its quarterly earnings results on Thursday, June, 11th. The company reported $0.01 EPS for the quarter. How do I buy shares of Sernova? Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Sernova own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova Biotherapeutics (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC). Company Calendar Last Earnings6/11/2026Today9/02/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolTSE:SVA CIKN/A Webwww.sinovacbio.com Phone861082890088FaxN/AEmployees1,959Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$35.70 million Net MarginsN/A Pretax MarginN/A Return on Equity55.85% Return on Assets-119.26% Debt Debt-to-Equity Ratio-25.45 Current Ratio0.14 Quick Ratio18.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.02 per share Price / Cash Flow6.15 Book ValueC($0.03) per share Price / Book-4.19Miscellaneous Outstanding Shares377,643,000Free FloatN/AMarket CapC$43.43 million OptionableNot Optionable Beta-0.46 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (TSE:SVA) was last updated on 9/2/2026 by MarketBeat.com Staff. From Our PartnersThis little-known gold fund distributes cash every FridayGold pays no dividends, no interest, no yield - it just sits there. Yet investors are reportedly collecting up...Investors Alley | Sponsored#1 Stock to Own as Trump Launches Historic Mission Backing "Medical AI"The federal government is throwing its full support behind a new class of AI technology, in what's being calle...Stansberry Research | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredJon Najarian's #1 Energy Trade for 2026Elon Musk just built the largest private power network in American history. Hall of Fame Trader Jon Najarian s...Banyan Hill Publishing | SponsoredWhy Boston Ships In Natural Gas It Already Has at HomeA tanker called the Iberica Knutsen once sailed 2,272 miles from Trinidad and Tobago to deliver liquefied natu...Porter & Company | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
